ebomi
Colour theme
Sign in
Insider · CIK 0001493811

Weyer Christian

CIK 0001493811 Name as filed on the most recent filing

Filed as Weyer Christian (15)

17 transaction lines · from 15 filings · filed 2010-11-19 to 2020-04-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

17 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-04-27 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 15,557, disposed Open Form 4 filing 0001104659-20-053658
2020-02-27 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 9,901, disposed Open Form 4 filing 0001104659-20-027330
2020-01-27 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 67,991, disposed Open Form 4 filing 0001104659-20-007260
2019-12-27 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 194,842, disposed Open Form 4 filing 0001104659-19-076864
2019-11-27 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 105,716, disposed Open Form 4 filing 0001104659-19-069103
2019-11-26 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 437,300, disposed Open Form 4 filing 0001104659-19-068398
2019-11-25 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 185,500, disposed Open Form 4 filing 0001104659-19-068398
2019-11-19 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 131,750, disposed Open Form 4 filing 0001104659-19-065555
2019-11-13 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 80,410, disposed Open Form 4 filing 0001104659-19-064831
2019-03-01 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 34,352, disposed Open Form 4 filing 0001144204-19-011720
2018-11-29 S, Open-market sale Intercept Pharmaceuticals, Inc.ICPT 152,807, disposed Open Form 4 filing 0001144204-18-062413
2014-04-02 S, Open-market sale Fate Therapeutics IncFATE 20,395, disposed Open Form 4 filing 0001493811-14-000002
2014-04-01 S, Open-market sale Fate Therapeutics IncFATE 69,789, disposed Open Form 4 filing 0001493811-14-000002
2012-03-01 S, Open-market sale Amylin Pharmaceuticals IncAMLN 21,062, disposed Open Form 4 filing 0001264124-12-000084
2012-02-23 S, Open-market sale Amylin Pharmaceuticals IncAMLN 42,899, disposed Open Form 4 filing 0001264124-12-000064
2012-02-08 S, Open-market sale Amylin Pharmaceuticals IncAMLN 63,853, disposed Open Form 4 filing 0001264124-12-000039
2010-11-19 S, Open-market sale Amylin Pharmaceuticals IncAMLN 17,634, disposed Open Form 4 filing 0001454982-10-000099

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 17
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Weyer Christian, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001493811

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.